Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.21.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - $ / shares
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Conversion price per share     $ 0.22
Conversion of Series B Preferred Stock [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 15,625,000 468,619  
Conversion Of Series E 1 Preferred Stock [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 8,500,000    
Vesting description vesting in 2021 through 2023    
Common Stock Options [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 468,619    
Common Stock Warrants [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 7,493,575 46,154  
Conversion of Debentures [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 218,750 66,000  
Conversion of Debentures [Member] | Shares May Be Converted into Bridge Notes [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount   2,087,234  
Conversion price per share   $ 1.98  
Conversion of Redeemable Convertible Preferred Stock [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Antidilutive securities excluded from computation of net loss per share, amount 3,000,000 302,768  
Conversion price per share $ 0.16